Fresenius Medical Care AG KGaA Receivables 2010-2024 | FMS
Fresenius Medical Care AG KGaA receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
- Fresenius Medical Care AG KGaA receivables for the quarter ending September 30, 2024 were $3.605B, a 10.82% decline year-over-year.
- Fresenius Medical Care AG KGaA receivables for 2023 were $3.936B, a 0.57% increase from 2022.
- Fresenius Medical Care AG KGaA receivables for 2022 were $3.913B, a 7.38% decline from 2021.
- Fresenius Medical Care AG KGaA receivables for 2021 were $4.225B, a 14.01% increase from 2020.
| Fresenius Medical Care AG KGaA Annual Receivables (Millions of US $) |
|
|---|---|
| 2023 | $3,936 |
| 2022 | $3,913 |
| 2021 | $4,225 |
| 2020 | $3,706 |
| 2019 | $4,010 |
| 2018 | $4,051 |
| 2017 | $3,891 |
| 2016 | $3,745 |
| 2015 | $3,503 |
| 2014 | $3,397 |
| 2013 | $3,190 |
| 2012 | $3,157 |
| 2011 | $2,798 |
| 2010 | $2,573 |
| 2009 | $2,286 |
| Fresenius Medical Care AG KGaA Quarterly Receivables (Millions of US $) |
|
|---|---|
| 2024-09-30 | $3,605 |
| 2024-06-30 | $4,375 |
| 2024-03-31 | $4,397 |
| 2023-12-31 | $3,936 |
| 2023-09-30 | $4,043 |
| 2023-06-30 | $3,976 |
| 2023-03-31 | $4,289 |
| 2022-12-31 | $3,913 |
| 2022-09-30 | $4,001 |
| 2022-06-30 | $4,049 |
| 2022-03-31 | $4,366 |
| 2021-12-31 | $4,225 |
| 2021-09-30 | $4,068 |
| 2021-06-30 | $4,249 |
| 2021-03-31 | $4,695 |
| 2020-12-31 | $3,706 |
| 2020-09-30 | $3,963 |
| 2020-06-30 | $3,943 |
| 2020-03-31 | $4,232 |
| 2019-12-31 | $4,010 |
| 2019-09-30 | $3,992 |
| 2019-06-30 | $4,108 |
| 2019-03-31 | $4,489 |
| 2018-12-31 | $4,051 |
| 2018-09-30 | $4,054 |
| 2018-06-30 | $4,398 |
| 2018-03-31 | $4,792 |
| 2017-12-31 | $3,891 |
| 2017-09-30 | $3,890 |
| 2017-06-30 | $3,618 |
| 2017-03-31 | $4,033 |
| 2016-12-31 | $3,745 |
| 2016-09-30 | $3,792 |
| 2016-06-30 | $3,648 |
| 2016-03-31 | $3,838 |
| 2015-12-31 | $3,503 |
| 2015-09-30 | $3,464 |
| 2015-06-30 | $3,397 |
| 2015-03-31 | $3,333 |
| 2014-12-31 | $3,397 |
| 2014-09-30 | $3,333 |
| 2014-06-30 | $3,378 |
| 2014-03-31 | $3,252 |
| 2013-12-31 | $3,190 |
| 2013-09-30 | $3,143 |
| 2013-06-30 | $3,222 |
| 2013-03-31 | $3,174 |
| 2012-12-31 | $3,157 |
| 2012-09-30 | $2,955 |
| 2012-06-30 | $2,933 |
| 2012-03-31 | $3,099 |
| 2011-12-31 | $2,798 |
| 2011-09-30 | $2,803 |
| 2011-06-30 | $2,947 |
| 2011-03-31 | |
| 2010-12-31 | $2,573 |
| 2010-09-30 | $2,495 |
| 2010-06-30 | $2,259 |
| 2010-03-31 | $2,302 |
| 2009-12-31 | $2,286 |
| 2009-09-30 | $2,333 |
| 2009-06-30 | $2,267 |
| 2009-03-31 | $2,317 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $13.538B | $21.053B |
| Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable medical devices used in the treatment of End Stage Renal Disease (ESRD). Devices like Hemodialysis Machines, Peritoneal Dialysis Machines, Granuflo Concentrate Mixing Tanks and monitoring devices like the Crit-line platform are included in the company's product pipeline. The company primarily operates in - The Health Care Services segment: Consists of the company's Dialysis Services and the Care-Coordination (non-dialysis laboratory services). The Health Care Products segment: Comprises of the company's Dialysis machines, dialyzers, dialysis solutions, hemodialysis concentrates, bloodline systems, water treatment systems, dialysis drugs and other medical products.. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.066B | 26.11 |
| Intuitive Surgical (ISRG) | United States | $211.086B | 110.36 |
| Alcon (ALC) | Switzerland | $41.615B | 27.84 |
| Edwards Lifesciences (EW) | United States | $41.156B | 26.14 |
| IQVIA Holdings (IQV) | United States | $35.821B | 19.74 |
| IDEXX Laboratories (IDXX) | United States | $34.331B | 40.43 |
| DexCom (DXCM) | United States | $32.958B | 49.63 |
| Waters (WAT) | United States | $23.988B | 35.47 |
| STERIS (STE) | Ireland | $20.691B | 23.82 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.710B | 0.00 |
| Hologic (HOLX) | United States | $15.740B | 17.09 |
| Globus Medical (GMED) | United States | $12.364B | 31.31 |
| Sysmex ADR (SSMXY) | Japan | $11.726B | 0.00 |
| Penumbra (PEN) | United States | $10.120B | 99.13 |
| Masimo (MASI) | United States | $9.225B | 44.63 |
| Glaukos (GKOS) | United States | $8.623B | 0.00 |
| Teleflex (TFX) | United States | $8.419B | 13.43 |
| Integer Holdings (ITGR) | United States | $4.729B | 26.81 |
| Inari Medical (NARI) | United States | $4.657B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.967B | 0.00 |
| Veracyte (VCYT) | United States | $3.145B | 94.37 |
| Nihon Kohden (NHNKY) | Japan | $2.658B | 20.19 |
| LivaNova (LIVN) | United Kingdom | $2.623B | 15.14 |
| Tandem Diabetes Care (TNDM) | United States | $2.309B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.167B | 19.48 |
| TransMedics (TMDX) | United States | $1.920B | 60.85 |
| Integra LifeSciences Holdings (IART) | United States | $1.860B | 9.72 |
| Alphatec Holdings (ATEC) | United States | $1.641B | 0.00 |
| Artivion (AORT) | United States | $1.288B | 85.33 |
| RxSight (RXST) | United States | $1.225B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.083B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.911B | 0.00 |
| AxoGen (AXGN) | United States | $0.796B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.758B | 17.88 |
| IRadimed (IRMD) | United States | $0.750B | 40.53 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.732B | 12.44 |
| SiBone (SIBN) | United States | $0.700B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.693B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.658B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.599B | 31.55 |
| Treace Medical Concepts (TMCI) | United States | $0.543B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.503B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.458B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.449B | 0.00 |
| CVRx (CVRX) | United States | $0.428B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.418B | 22.60 |
| ClearPoint Neuro (CLPT) | United States | $0.415B | 0.00 |
| NeuroPace (NPCE) | United States | $0.357B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.273B | 0.00 |
| Inogen (INGN) | United States | $0.249B | 0.00 |
| Accuray (ARAY) | United States | $0.225B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.187B | 0.00 |
| Nevro (NVRO) | United States | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.144B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.108B | 11.51 |
| Atossa Genetics (ATOS) | United States | $0.104B | 0.00 |
| 908 Devices (MASS) | United States | $0.104B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.098B | 0.00 |
| LENSAR (LNSR) | United States | $0.097B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.094B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.088B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| Neuronetics (STIM) | United States | $0.075B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.071B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.93 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.058B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.053B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Spectral AI (MDAI) | United States | $0.036B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.027B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.020B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.008B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |